Table 2 Univariate analyses of clinical characteristics for tumor-related death, metastasis, and local recurrence in Chinese patients with lacrimal gland adenoid cystic carcinoma
From: Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma
Characteristics | Total | Recurrence (+) | Recurrence (−) | P | Metastasis (+) | Metastasis (−) | P | Tumor-related death (+) | Tumor-related death (−) | P |
|---|---|---|---|---|---|---|---|---|---|---|
Sex | 24 | 0.668 | 0.818 | 0.540 | ||||||
Male, no. (%) | 13 (54.2) | 9 (60.0) | 4 (44.4) | 6 (54.5) | 7 (53.8) | 5 (62.5) | 8 (50.0) | |||
Female, no. (%) | 11 (45.8) | 6 (40.0) | 5 (55.6) | 5 (45.5) | 6 (41.2) | 3 (37.5) | 8 (50.0) | |||
Age y | 53.2 ± 12.9 | 52.2 ± 14.8 | 54.9 ± 9.4 | 0.901 | 54.8 ± 15.9 | 51.9 ± 10.2 | 0.407 | 51.1 ± 16.2 | 54.3 ± 11.3 | 0.990 |
Affected Side | 24 | 0.740 | 0.979 | 0.398 | ||||||
Right, no. (%) | 10 (41.7) | 7 (46.7) | 3 (33.3) | 5 (45.5) | 5 (38.5) | 5 (62.5) | 5 (31.3) | |||
Lift, no. (%) | 14 (58.3) | 8 (53.3) | 6 (66.7) | 6 (54.5) | 8 (61.5) | 3 (37.5) | 11 (68.7) | |||
RT | 0.319 | 0.626 | 0.894 | |||||||
Yes, no. (%) | 20 (83.3) | 12 (80.0) | 8 (88.9) | 10 (90.9) | 10 (76.9) | 7 (87.5) | 13 (81.3) | |||
No, no. (%) | 4 (16.7) | 3 (20.0) | 1 (11.1) | 1 (9.1) | 3 (23.1) | 1 (12.5) | 3 (18.7) | |||
CT | 0.326 | 0.193 | 0.299 | |||||||
Yes, no. (%) | 10 | 7 (46.7) | 3 (33.3) | 6 (54.5) | 4 (30.8) | 4 (50.0) | 6 (37.5) | |||
No, no. (%) | 14 | 8 (53.3) | 6 (66.7) | 5 (45.5) | 9 (69.2) | 4 (50.0) | 10 (62.5) | |||
diameter mm | 29.1 ± 11.0 | 32.0 ± 12.3 | 24.3 ± 6.4 | 0.032* | 33.0 ± 13.4 | 25.8 ± 7.6 | 0.045* | 38.3 ± 11.5 | 24.6 ± 7.6 | 0.004* |
PNI | 0.234 | 0.890 | 0.345 | |||||||
Yes, no. (%) | 13 | 9 (60.0) | 4 (44.4) | 6 (54.5) | 7 (53.8) | 5 (62.5) | 8 (50.0) | |||
No, no. (%) | 11 | 6 (40.0) | 5 (55.6) | 5 (45.5) | 6 (41.2) | 3 (37.5) | 8 (50.0) |